{"content":"<li class=\"n-box-item date-title\" data-end=\"1555473599\" data-start=\"1555387200\" data-txt=\"Monday, December 23, 2019\">Tuesday, April 16, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3451293\" data-ts=\"1555451874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451293-report-doj-opposes-t-mobile-sprint-merger-simply-untrue-ceo-legere-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report DoJ opposes T-Mobile-Sprint merger &#39;simply untrue,&#39; CEO Legere says</a></h4><ul><li>T-Mobile US (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) CEO John Legere says the <a href=\"https://seekingalpha.com/news/3451259-sprint-t-mobile-lower-doj-resistance\" target=\"_blank\"><em>WSJ</em> report</a> that its merger deal with Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) likely will not be approved by the U.S. Department of Justice is \"<a href=\"https://twitter.com/JohnLegere/status/1118265746453192704\" target=\"_blank\">simply untrue</a>.\"</li><li>\"The premise of this  story, as summarized in the first paragraph, is simply untrue,\" Legere tweets. \"Out of respect for the process, we have no further comment.\"</li><li>In a meeting earlier this month, Justice Department staff members laid out their concerns with the deal and questioned the companies' arguments that the merger would produce important efficiencies, according to the <em>WSJ</em> report.</li><li>TMUS <font color=\"red\">-3.9%</font>, S <font color=\"red\">-8.3%</font> after-hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451293\" data-linked=\"Report DoJ opposes T-Mobile-Sprint merger &#39;simply untrue,&#39; CEO Legere says\" data-tweet=\"$TMUS $S - Report DoJ opposes T-Mobile-Sprint merger &#39;simply untrue,&#39; CEO Legere says https://seekingalpha.com/news/3451293-report-doj-opposes-t-mobile-sprint-merger-simply-untrue-ceo-legere-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3451293-report-doj-opposes-t-mobile-sprint-merger-simply-untrue-ceo-legere-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451289\" data-ts=\"1555450331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APO\" target=\"_blank\">APO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451289-smart-finalplus-19-on-pact-to-be-acquired\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smart &amp; Final +19% on pact to be acquired</a></h4><ul><li>Smart &amp; Final Stores (NYSE:<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores, Inc.'>SFS</a>) <font color=\"green\">rises 19%</font>  to $6.40 in after-hours trading after <a href=\"https://seekingalpha.com/pr/17478966-smart-and-final-agrees-acquired-funds-managed-affiliates-apollo-global-management\" target=\"_blank\">agreeing to be acquired</a> by certain investment funds managed by affiliates of Apollo Global Management (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>) for $6.50 per share in cash.</li><li>Smart &amp; Final's majority shareholder, Ares Management (NYSE:<a href='https://seekingalpha.com/symbol/ARES' title='Ares Management Corporation'>ARES</a>), agree to tender its shares in the offer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3442860-smart-and-final-stores-slides-15_9-percent-post-q4-results\" target=\"_blank\">Smart &amp; Final Stores slides 15.9% post Q4 results</a> (March 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451289\" data-linked=\"Smart &amp; Final +19% on pact to be acquired\" data-tweet=\"$APO $SFS $ARES - Smart &amp; Final +19% on pact to be acquired https://seekingalpha.com/news/3451289-smart-finalplus-19-on-pact-to-be-acquired?source=tweet\" data-url=\"https://seekingalpha.com/news/3451289-smart-finalplus-19-on-pact-to-be-acquired\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451288\" data-ts=\"1555450073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451288-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/CADE' title='Cadence Bancorporation'>CADE</a> <font color=\"green\">+20.6%</font>. <a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color=\"green\">+6.6%</font>. <a href='https://seekingalpha.com/symbol/JMIA' title='Jumia Technologies AG'>JMIA</a> <font color=\"green\">+5.7%</font>. <a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals, Inc.'>RARX</a> <font color=\"green\">+4.4%</font>. <a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color=\"green\">+4.4%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a> <font color=\"red\">-6.7%</font>. <a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color=\"red\">-6.1%</font>. <a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color=\"red\">-5.4%</font>. <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color=\"red\">-4.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451288\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CADE $ADVM $JMIA - After Hours Gainers / Losers https://seekingalpha.com/news/3451288-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451288-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451283\" data-ts=\"1555449258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQBG\" target=\"_blank\">SQBG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451283-sequential-brands-up-40-on-deal-to-sell-martha-stewart-emeril-lagasse-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sequential Brands up 40% on deal to sell Martha Stewart/Emeril Lagasse brands</a></h4><ul><li>The buyer is Marquee Brands, and the price is an estimated $175M, with possible earnout of up to another $40M.</li><li>The deal is seen closing in Q2.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17478914-sequential-brands-group-signs-definitive-agreement-sell-martha-stewart-emeril-lagasse-brands\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color=\"green\">+40.35%</font> to $1.60.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451283\" data-linked=\"Sequential Brands up 40% on deal to sell Martha Stewart/Emeril Lagasse brands\" data-tweet=\"$SQBG - Sequential Brands up 40% on deal to sell Martha Stewart/Emeril Lagasse brands https://seekingalpha.com/news/3451283-sequential-brands-up-40-on-deal-to-sell-martha-stewart-emeril-lagasse-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3451283-sequential-brands-up-40-on-deal-to-sell-martha-stewart-emeril-lagasse-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451259\" data-ts=\"1555446800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451259-sprint-t-mobile-lower-on-doj-resistance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint, T-Mobile lower on DOJ resistance</a></h4><ul><li>The DOJ has told the two companies that their merger deal isn't likely to be approved as currently structured, <a href=\"https://www.wsj.com/articles/t-mobile-sprint-deal-runs-into-resistance-from-doj-antitrust-staff-11555446461?mod=searchresults&amp;page=1&amp;pos=1\" target=\"_blank\">reports the WSJ</a>.</li><li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <font color=\"red\">-8.8%</font>, T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) <font color=\"red\">-2.8%</font> in after hours action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451259\" data-linked=\"Sprint, T-Mobile lower on DOJ resistance\" data-tweet=\"$S $TMUS - Sprint, T-Mobile lower on DOJ resistance https://seekingalpha.com/news/3451259-sprint-t-mobile-lower-on-doj-resistance?source=tweet\" data-url=\"https://seekingalpha.com/news/3451259-sprint-t-mobile-lower-on-doj-resistance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451247\" data-ts=\"1555446122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451247-csxplus-4-after-huge-efficiency-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSX +4% after huge efficiency gains</a></h4><ul>  <li>CSX Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a>) reports a quarterly record operating ratio of 59.5%, a mark that smashed the 63.7% recorded a year ago.</li> <li>Revenue in Q1 rose 5% to $3.01B to just edge past the consensus estimate of analysts. CSX management says merchandise volume growth and broad-based pricing gains stoked the revenue growth.</li> <li>Expenses fell 2% to $1.89B during the quarter as efficiency efforts paid off.</li> <li>\"These results reflect the strength of our company\u2019s operating model and our commitment to providing a best-in-class service offering to our customers\" says CSX CEO James Foote.</li> <li>CSX <font color=\"green\">+4.0%</font> AH after trading flat on the day before the report.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451225-csx-beats-0_11-beats-revenue\" target=\"_blank\">CSX beats by $0.11, beats on revenue</a> (April 16)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451247\" data-linked=\"CSX +4% after huge efficiency gains\" data-tweet=\"$CSX - CSX +4% after huge efficiency gains https://seekingalpha.com/news/3451247-csxplus-4-after-huge-efficiency-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3451247-csxplus-4-after-huge-efficiency-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451246\" data-ts=\"1555446093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451246-ibms-mixed-q1-on-slowing-cloud-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM&#39;s mixed Q1 on slowing cloud growth</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <font color=\"red\">drops 1.7%</font> after reporting Q1 results that beat EPS estimates but missed on revenue with sales down 5% Y/Y.</li><li>The company reaffirms its FY19 EPS guidance of at least $13.90 with FCF of approximately $12B.</li><li>Revenue breakdown: Cloud and Cognitive Software, $5B (-2% Y/Y); Global Business Services, $4.1B (flat); Global Technology Services, $6.9B (-7%); Systems, $1.3B (-11%); Global Financing, $406M (flat).</li><li>Cloud revenue grew 10% Y/Y or 12% in constant currency over the last 12 months to $19.5B, flat with the 12% Y/Y growth in Q4.</li><li>As-a-service annual exit run rate for cloud revenue was also up 10% to $11.7B.</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ibm.com%2Finvestor%2Fevents%2Fearnings%2F1q19.html&amp;esheet=51970585&amp;newsitemid=20190416005959&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.ibm.com%2Finvestor%2Fevents%2Fearnings%2F1q19.html&amp;index=1&amp;md5=de4021610809f5801cb6ba357830a088\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17478805-ibm-reports-2019-first-quarter-results\" target=\"_blank\">Press release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3451229-international-business-machines-beats-0_01-misses-revenue\" target=\"_blank\">International Business Machines beats by $0.01, misses on revenue</a> (April 16)</li><li>Post updated to correct the constant currency cloud revenue growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451246\" data-linked=\"IBM&#39;s mixed Q1 on slowing cloud growth\" data-tweet=\"$IBM - IBM&#39;s mixed Q1 on slowing cloud growth https://seekingalpha.com/news/3451246-ibms-mixed-q1-on-slowing-cloud-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3451246-ibms-mixed-q1-on-slowing-cloud-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451242\" data-ts=\"1555445776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRA\" target=\"_blank\">NTRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451242-natera-files-for-100m-stock-offering-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natera files for $100M stock offering; shares down 5% after hours</a></h4><ul><li>Natera (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1604821/000104746919002277/a2238456zs-3asr.htm\" target=\"_blank\">preliminary prospectu</a>s for a $100M public offering of common stock. Price, volume and terms have yet to be released.</li><li>Shares are down <font color=\"red\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451242\" data-linked=\"Natera files for $100M stock offering; shares down 5% after hours\" data-tweet=\"$NTRA - Natera files for $100M stock offering; shares down 5% after hours https://seekingalpha.com/news/3451242-natera-files-for-100m-stock-offering-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3451242-natera-files-for-100m-stock-offering-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451225\" data-ts=\"1555445020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451225-csx-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CSX beats by $0.11, beats on revenue</a></h4><ul><li>CSX (NASDAQ:<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a>): Q1 GAAP EPS of $1.02 <span style=\"color:green\">beats by $0.11</span>.</li><li>Revenue of $3.01B (+4.5% Y/Y) <font color=\"green\">beats by $10M</font>.</li><li>Shares <font color=\"green\">+2.2%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17478780-csx-announces-record-first-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3451225\" data-linked=\"CSX beats by $0.11, beats on revenue\" data-tweet=\"$CSX - CSX beats by $0.11, beats on revenue https://seekingalpha.com/news/3451225-csx-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3451225-csx-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451214\" data-ts=\"1555443341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451214-sesen-bio-up-24-ahead-of-key-data-readout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sesen Bio up 24% ahead of key data readout</a></h4><ul><li>Micro cap Sesen Bio (<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a> <font color=\"green\">+23.9%</font>) is up more than a 7x surge in volume. No particular news accounts for the action but a key catalyst should happen later this quarter.</li><li>Preliminary efficacy data from the third cohort in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02449239?term=vicinium&amp;rank=1\" target=\"_blank\">VISTA</a>, evaluating lead drug Vicinium in patients with treatment-resistant high-grade non-muscle bladder cancer, a Fast Track indication in the U.S., should be available in June. Data on secondary endpoints will be reported as well.</li><li>The company <a href=\"https://seekingalpha.com/news/3420273-sesen-bio-22-percent-premarket-late-stage-vicinium-data\" target=\"_blank\">reported</a> interim data from the first two cohorts in January that showed statistically significant response rates.</li><li>On the working capital front, at year-end 2018 it had $50.4M in cash and equivalents while operations consumed $22.8M during the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451214\" data-linked=\"Sesen Bio up 24% ahead of key data readout\" data-tweet=\"$SESN - Sesen Bio up 24% ahead of key data readout https://seekingalpha.com/news/3451214-sesen-bio-up-24-ahead-of-key-data-readout?source=tweet\" data-url=\"https://seekingalpha.com/news/3451214-sesen-bio-up-24-ahead-of-key-data-readout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451212\" data-ts=\"1555442619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451212-boeing-needs-boardroom-shake-up-advisory-firms-say-ft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing needs boardroom shake-up, advisory firms say - FT</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.8%</font>) faces an investor backlash in the wake of the two fatal 737 MAX accidents, with two leading shareholder advisory firms <a href=\"https://www.ft.com/content/93d806fe-605c-11e9-b285-3acd5d43599e\" target=\"_blank\">calling for a boardroom shake-up</a>, <em>Financial Times</em> reports.</li><li><em>FT</em> says Institutional Shareholder Services has told clients that Dennis Muilenburg should be stripped of his dual role as Chairman and CEO, and believes Boeing should appoint an independent chairman to help rebuild its reputation.</li><li>ISS also recommends shareholder support for a proposal for Boeing to increase disclosure of its spending on government lobbying, as the company\u2019s relationship with the Federal Aviation Administration and its lobbying efforts are under scrutiny.</li><li>Meanwhile, Glass Lewis reportedly wants the removal of the board's audit committee head Lawrence Kellner for failing to foresee 737 MAX safety risks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451212\" data-linked=\"Boeing needs boardroom shake-up, advisory firms say - FT\" data-tweet=\"$BA - Boeing needs boardroom shake-up, advisory firms say - FT https://seekingalpha.com/news/3451212-boeing-needs-boardroom-shake-up-advisory-firms-say-ft?source=tweet\" data-url=\"https://seekingalpha.com/news/3451212-boeing-needs-boardroom-shake-up-advisory-firms-say-ft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451211\" data-ts=\"1555442389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451211-qualcomm-pushes-semis-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm pushes semis to new high</a></h4><ul><li>The Philadelphia Semiconductor Index <font color=\"green\">jumps 2.6%</font> to a new record high after Apple and Qualcomm settle all litigation around the world.</li><li>Top components on the move (other than QCOM) include Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne, Inc.'>TER</a> <font color='green'>+2.8%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc.'>QRVO</a> <font color='green'>+2.5%</font>), and MKS Instruments (<a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a> <font color='green'>+3.1%</font>).</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3451208-qualcomm-apple-drop-litigation-qcom-plus-14_7-percent\" target=\"_blank\">Qualcomm, Apple drop all litigation; QCOM +14.7%</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451211\" data-linked=\"Qualcomm pushes semis to new high\" data-tweet=\"$TER $QRVO $MKSI - Qualcomm pushes semis to new high https://seekingalpha.com/news/3451211-qualcomm-pushes-semis-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3451211-qualcomm-pushes-semis-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451210\" data-ts=\"1555442274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SC\" target=\"_blank\">SC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451210-santander-consumer-usa-loses-bear\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Santander Consumer USA loses a bear</a></h4><ul><li>Santander Consumer USA (<a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc.'>SC</a> <font color='green'>+1.9%</font>) <a href=\"https://www.americanbankingnews.com/2019/04/16/santander-consumer-usa-sc-upgraded-by-jpmorgan-chase-co-to-neutral.html\" target=\"_blank\">raised</a> to neutral from underweight by JPMorgan analysts.</li><li>Price target to $23 from $20.</li><li><a href=\"https://seekingalpha.com/symbol/SC/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>; average price target $23.39.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431603-likelihood-santander-consumer-usa-buyout-just-rose-analyst-say\" target=\"_blank\">Likelihood of Santander Consumer USA buyout just rose, analyst say</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451210\" data-linked=\"Santander Consumer USA loses a bear\" data-tweet=\"$SC - Santander Consumer USA loses a bear https://seekingalpha.com/news/3451210-santander-consumer-usa-loses-bear?source=tweet\" data-url=\"https://seekingalpha.com/news/3451210-santander-consumer-usa-loses-bear\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451205\" data-ts=\"1555440713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451205-rokuplus-2-after-bullish-note-on-disney-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +2% after bullish note on Disney+ potential</a></h4><ul><li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) shares are<font color=\"green\"> up 2%</font> after this morning's Needham note calling the upcoming Disney+ streaming service a potential \"$1B upside driver\" for Roku.</li><li>Analyst Laura Martin thinks Disney+ could add $187M in new revenue in 2024, representing both subscription revenue and marketing spending.</li><li>Martin has a Buy rating and $85 PT on Roku.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451205\" data-linked=\"Roku +2% after bullish note on Disney+ potential\" data-tweet=\"$ROKU - Roku +2% after bullish note on Disney+ potential https://seekingalpha.com/news/3451205-rokuplus-2-after-bullish-note-on-disney-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3451205-rokuplus-2-after-bullish-note-on-disney-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451199\" data-ts=\"1555439624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451199-vale-ok-to-resume-operations-brucutu-mine-brazilian-court-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale OK to resume operations at Brucutu mine, Brazilian court says</a></h4><ul><li>Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto Group'>RIO</a> <font color=\"red\">-3.4%</font>), Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a> <font color=\"red\">-4.6%</font>) and BHP (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Group'>BHP</a> <font color=\"red\">-1.1%</font>) all turn sharply lower following reports that Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"green\">+2.1%</font>) has received <a href=\"https://www.reuters.com/article/vale-sa-disaster-production/brazilian-court-authorizes-vale-to-resume-ops-at-brucutu-mine-municipality-idUSE6N20K01K\" target=\"_blank\">authorization to reopen</a> its Brucutu mine.</li><li>Vale had been ordered in early February to halt operations at the iron ore mine, the largest in Minas Gerais state, following the deadly tailings dam disaster in the state.</li><li>Vale was authorized early last month to resume operations but was blocked by a court injunction; now the Minas Gerais state court gave final approval to resume production at Brucutu.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451199\" data-linked=\"Vale OK to resume operations at Brucutu mine, Brazilian court says\" data-tweet=\"$RIO $CLF $BHP - Vale OK to resume operations at Brucutu mine, Brazilian court says https://seekingalpha.com/news/3451199-vale-ok-to-resume-operations-brucutu-mine-brazilian-court-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3451199-vale-ok-to-resume-operations-brucutu-mine-brazilian-court-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451198\" data-ts=\"1555439591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451198-tigr-uxin-and-hive-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TIGR, UXIN and HIVE among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network, Inc.'>IPDN</a>) <font color=\"green\">+17%</font>. UP Fintech Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TIGR' title='UP Fintech Holding Limited'>TIGR</a>) <font color=\"green\">+14%</font>. Asure Software (NASDAQ:<a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a>) <font color=\"green\">+10%</font>. Opera (NASDAQ:<a href='https://seekingalpha.com/symbol/OPRA' title='Opera Limited'>OPRA</a>) <font color=\"green\">+9%</font>. MicroVision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='MicroVision, Inc.'>MVIS</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers: </strong>Uxin Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"red\">-33%</font>. Aerohive Networks (NYSE:<a href='https://seekingalpha.com/symbol/HIVE' title='Aerohive Networks, Inc.'>HIVE</a>) <font color=\"red\">-18%</font>. Phunware (PHUN) <font color=\"red\">-15%</font>. Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) <font color=\"red\">-15%</font>. Cool Holdings, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451198\" data-linked=\"TIGR, UXIN and HIVE among notable tech movers\" data-tweet=\"$IPDN $TIGR $ASUR - TIGR, UXIN and HIVE among notable tech movers https://seekingalpha.com/news/3451198-tigr-uxin-and-hive-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451198-tigr-uxin-and-hive-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451197\" data-ts=\"1555439519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKT\" target=\"_blank\">SKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451197-rough-session-for-reits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A very rough session for REITs</a></h4><ul><li>Scotiabank figures the occupancy risk to mall players like Tanger Factory (<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='red'>-4.5%</font>), Macerich (<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Company'>MAC</a> <font color='red'>-6.4%</font>), Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='red'>-4.2%</font>), and Taubman (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color='red'>-4.8%</font>) is at least double that of shopping center owners like Regency (<a href='https://seekingalpha.com/symbol/REG' title='Regency Centers Corporation'>REG</a> <font color='red'>-3%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='red'>-3.3%</font>), Brixmor (<a href='https://seekingalpha.com/symbol/BRX' title='Brixmor Property Group Inc.'>BRX</a> <font color='red'>-2.6%</font>), Federal Realty (<a href='https://seekingalpha.com/symbol/FRT' title='Federal Realty Investment Trust'>FRT</a> <font color='red'>-3.2%</font>), and Weingarten (<a href='https://seekingalpha.com/symbol/WRI' title='Weingarten Realty Investors'>WRI</a> <font color='red'>-2.7%</font>). Why? Malls have more apparel exposure, and that's where retailer bankruptcy risk is greatest.</li><li>The carnage in the REIT sector today, however, is very much across the board as the 10-year Treasury yield continues to rise - now just shy of touching 2.60%.</li><li>Realty Income (<a href='https://seekingalpha.com/symbol/O' title='Realty Income Corporation'>O</a> <font color='red'>-2.8%</font>), Omega Healthcare (<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc.'>OHI</a> <font color='red'>-2.4%</font>), Ventas (<a href='https://seekingalpha.com/symbol/VTR' title='Ventas, Inc.'>VTR</a> <font color='red'>-3.6%</font>), Senior Housing (<a href='https://seekingalpha.com/symbol/SNH' title='Senior Housing Properties Trust'>SNH</a> <font color='red'>-1.4%</font>), National Retail (<a href='https://seekingalpha.com/symbol/NNN' title='National Retail Properties, Inc.'>NNN</a> <font color='red'>-3.6%</font>), Stag Industrial (<a href='https://seekingalpha.com/symbol/STAG' title='STAG Industrial, Inc.'>STAG</a> <font color='red'>-2.1%</font>), Prologis (<a href='https://seekingalpha.com/symbol/PLD' title='Prologis, Inc.'>PLD</a> <font color='red'>-1.7%</font>), W.P. Carey (<a href='https://seekingalpha.com/symbol/WPC' title='W. P. Carey Inc.'>WPC</a> <font color='red'>-2.5%</font>), Public Storage (<a href='https://seekingalpha.com/symbol/PSA' title='Public Storage'>PSA</a> <font color='red'>-1.6%</font>), Equity Residential (<a href='https://seekingalpha.com/symbol/EQR' title='Equity Residential'>EQR</a> <font color='red'>-2.5%</font>).</li><li>The Vanguard Real Estate Index Fund (<a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a> <font color='red'>-2.3%</font>), The iShares U.S. Real Estate ETF (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-2.2%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3451197\" data-linked=\"A very rough session for REITs\" data-tweet=\"$SKT $MAC $SPG - A very rough session for REITs https://seekingalpha.com/news/3451197-rough-session-for-reits?source=tweet\" data-url=\"https://seekingalpha.com/news/3451197-rough-session-for-reits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>229&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451193\" data-ts=\"1555439238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VUZI\" target=\"_blank\">VUZI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451193-vuzixplus-5_5-on-in-stock-smart-glasses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vuzix +5.5% on in stock Smart Glasses</a></h4><ul><li>Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) shares are <font color=\"green\">up 5.5%</font> after the company <a href=\"https://seekingalpha.com/pr/17478610-vuzix-boosts-blade-production-expands-functionality\" target=\"_blank\">announces</a> it can offer \"near immediate delivery\" on new Blade AR Smart Glasses orders through its website.</li><li>The Smart Glasses did have a shipping time of three to four weeks due to low production yields for optical waveguides.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451193\" data-linked=\"Vuzix +5.5% on in stock Smart Glasses\" data-tweet=\"$VUZI - Vuzix +5.5% on in stock Smart Glasses https://seekingalpha.com/news/3451193-vuzixplus-5_5-on-in-stock-smart-glasses?source=tweet\" data-url=\"https://seekingalpha.com/news/3451193-vuzixplus-5_5-on-in-stock-smart-glasses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451192\" data-ts=\"1555439072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451192-boeing-finalizes-fixes-for-737-max-jets-shares-pop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing finalizes fixes for 737 MAX jets; shares pop</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"green\">+1.3%</font>) shares jump following reports that the Federal Aviation Administration's flight standardization board has classified the anti-stall software update to its grounded 737 MAX jets as \"<a href=\"https://www.reuters.com/article/us-ethiopia-airplane-faa/faa-panel-finds-boeing-737-max-software-upgrade-operationally-suitable-idUSKCN1RS1ZR?il=0\" target=\"_blank\">operationally suitable</a>.\"</li><li>The initial review also recommends  that pilots take additional computer-based training for the MCAS  anti-stall system.</li><li>Boeing had said earlier this month it would submit a software upgrade and additional training for the MCAS to the FAA in the coming weeks for approval.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451192\" data-linked=\"Boeing finalizes fixes for 737 MAX jets; shares pop\" data-tweet=\"$BA - Boeing finalizes fixes for 737 MAX jets; shares pop https://seekingalpha.com/news/3451192-boeing-finalizes-fixes-for-737-max-jets-shares-pop?source=tweet\" data-url=\"https://seekingalpha.com/news/3451192-boeing-finalizes-fixes-for-737-max-jets-shares-pop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451188\" data-ts=\"1555437872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451188-quintana-energy-services-and-mcdermott-among-energy-materials-gainers-bristow-group-and-altus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quintana Energy Services and McDermott among Energy/Materials gainers; Bristow Group and Altus Midstream among losers</a></h4><ul><li><b>Gainers: </b>Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"green\">+11%</font>. McDermott (NYSE:<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a>) <font color=\"green\">+11%</font>. FTS International (NYSE:<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a>) <font color=\"green\">+11%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+7%</font>. Piedmont Lithium (NASDAQ:<a href='https://seekingalpha.com/symbol/PLL' title='Piedmont Lithium Limited'>PLL</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-47%</font>. Altus Midstream (NASDAQ:<a href='https://seekingalpha.com/symbol/ALTM' title='Altus Midstream Company'>ALTM</a>) <font color=\"red\">-9%</font>. Martin Midstream Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/MMLP' title='Martin Midstream Partners L.P.'>MMLP</a>) <font color=\"red\">-8%</font>. Yamana Gold (NYSE:<a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a>) <font color=\"red\">-8%</font>. SemGroup (NYSE:<a href='https://seekingalpha.com/symbol/SEMG' title='SemGroup Corporation'>SEMG</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451188\" data-linked=\"Quintana Energy Services and McDermott among Energy/Materials gainers; Bristow Group and Altus Midstream among losers\" data-tweet=\"$QES $MDR $FTSI - Quintana Energy Services and McDermott among Energy/Materials gainers; Bristow Group and Altus Midstream among losers https://seekingalpha.com/news/3451188-quintana-energy-services-and-mcdermott-among-energy-materials-gainers-bristow-group-and-altus?source=tweet\" data-url=\"https://seekingalpha.com/news/3451188-quintana-energy-services-and-mcdermott-among-energy-materials-gainers-bristow-group-and-altus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451180\" data-ts=\"1555435892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451180-lannett-down-4-on-cautious-sa-article-on-alleged-price-collusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lannett down 4% on cautious SA article on alleged price collusion</a></h4><ul><li>Lannett Company (<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a> <font color=\"red\">-3.8%</font>) slips on below-average volume on the heels of an <a href=\"https://seekingalpha.com/article/4254726-lannett-generic-price-gouging-suit-names-names-might-death-blow\" target=\"_blank\">article </a>on Seeking Alpha by The Capitolist about an investigation into price collusion by the Connecticut AG's office.</li><li>According to the <a href=\"https://www.courant.com/nation-world/hc-pol-generic-drug-cartel-20181210-story.html\" target=\"_blank\">Hartford Courant</a>, AG George Jepsen is looking price-fixing involving at least 16 companies and 300 medicines.</li><li>The Capitolist believes that a potential fine of ~$200M - 300M, if levied against LCI, could bankrupt the company.</li><li>Unsurprisingly, generic drug makers reject the accusations citing the lack of evidence of a conspiracy or anti-competitive behavior.</li><li>Targeted companies include Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"green\">+1.1%</font>); Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a> <font color=\"red\">-0.1%</font>), Dr. Reddy's Laboratories (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"red\">-0.4%</font>); Novartis (Sandoz) (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451180\" data-linked=\"Lannett down 4% on cautious SA article on alleged price collusion\" data-tweet=\"$LCI $TEVA $MYL - Lannett down 4% on cautious SA article on alleged price collusion https://seekingalpha.com/news/3451180-lannett-down-4-on-cautious-sa-article-on-alleged-price-collusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3451180-lannett-down-4-on-cautious-sa-article-on-alleged-price-collusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451175\" data-ts=\"1555434696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMX\" target=\"_blank\">NYMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451175-nymox-up-6-after-fda-meeting-on-lead-drug-application\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox up 6% after FDA meeting on lead drug application</a></h4><ul><li>Thinly traded micro cap Nymox Pharmaceutical (<a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color=\"green\">+6.4%</font>) is up on double normal volume, albeit on turnover of only 162K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17478546-nymox-reports-pre-nda-cmc-meeting-fda\" target=\"_blank\">meeting </a>with the FDA to discuss part of the data package &#40;CMC&#41; for its marketing application for fexapotide triflutate for benign prostatic hyperplasia (enlarged prostate).</li><li>The company says the agency's review team had no serious issues with the information.</li><li>It expects to complete the filing later this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451175\" data-linked=\"Nymox up 6% after FDA meeting on lead drug application\" data-tweet=\"$NYMX - Nymox up 6% after FDA meeting on lead drug application https://seekingalpha.com/news/3451175-nymox-up-6-after-fda-meeting-on-lead-drug-application?source=tweet\" data-url=\"https://seekingalpha.com/news/3451175-nymox-up-6-after-fda-meeting-on-lead-drug-application\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451173\" data-ts=\"1555434142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451173-exone-and-forterra-among-industrial-gainers-fuel-tech-and-ocean-power-technologies-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The ExOne and Forterra among industrial gainers; Fuel Tech and Ocean Power Technologies among losers</a></h4><ul><li><b>Gainers: </b>Limbach Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LMB' title='Limbach Holdings, Inc.'>LMB</a>) <font color=\"green\">+8%</font>. Forterra (NASDAQ:<a href='https://seekingalpha.com/symbol/FRTA' title='Forterra, Inc.'>FRTA</a>) <font color=\"green\">+8%</font>. Quest Resource Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/QRHC' title='Quest Resource Holding Corporation'>QRHC</a>) <font color=\"green\">+6%</font>. The ExOne (NASDAQ:<a href='https://seekingalpha.com/symbol/XONE' title='The ExOne Company'>XONE</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"red\">-7%</font>. Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"red\">-7%</font>. Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451173\" data-linked=\"The ExOne and Forterra among industrial gainers; Fuel Tech and Ocean Power Technologies among losers\" data-tweet=\"$LMB $FRTA $QRHC - The ExOne and Forterra among industrial gainers; Fuel Tech and Ocean Power Technologies among losers https://seekingalpha.com/news/3451173-exone-and-forterra-among-industrial-gainers-fuel-tech-and-ocean-power-technologies-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3451173-exone-and-forterra-among-industrial-gainers-fuel-tech-and-ocean-power-technologies-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451168\" data-ts=\"1555433951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451168-360-finance-leads-financial-gainers-senmiao-technology-and-macerich-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">360 Finance leads financial gainers; Senmiao Technology and Macerich among losers</a></h4><ul><li><b>Gainers:</b> 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"green\">+12%</font>. Noah Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a>) <font color=\"green\">+9%</font>. Drive Shack (NYSE:<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc.'>DS</a>) <font color=\"green\">+8%</font>. Plumas Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PLBC' title='Plumas Bancorp'>PLBC</a>) <font color=\"green\">+7%</font>. The Progressive (NYSE:<a href='https://seekingalpha.com/symbol/PGR' title='The Progressive Corporation'>PGR</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance Limited'>XRF</a>) <font color=\"red\">-12%</font>. Senmiao Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology Limited'>AIHS</a>) <font color=\"red\">-6%</font>. Mogo Finance Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MOGO' title='Mogo Finance Technology Inc.'>MOGO</a>) <font color=\"red\">-5%</font>. China Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Bat Group, Inc.'>GLG</a>) <font color=\"red\">-5%</font>. Macerich (NYSE:<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Company'>MAC</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451168\" data-linked=\"360 Finance leads financial gainers; Senmiao Technology and Macerich among losers\" data-tweet=\"$QFIN $NOAH $DS - 360 Finance leads financial gainers; Senmiao Technology and Macerich among losers https://seekingalpha.com/news/3451168-360-finance-leads-financial-gainers-senmiao-technology-and-macerich-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451168-360-finance-leads-financial-gainers-senmiao-technology-and-macerich-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451170\" data-ts=\"1555433881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451170-pg-and-e-defends-new-board-amid-skeptic-regulators\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E defends new board amid skeptic regulators</a></h4><ul><li>Outgoing PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-3.2%</font>) board chairman Richard Kelly appeared before the  California Public Utilities Commission yesterday to <a href=\"https://abc7news.com/business/pg-e-defends-new-board-at-public-hearing/5252489/\" target=\"_blank\">defend the new selections</a> for the utility's board.</li><li>California Gov. Newsom and others had <a href=\"https://seekingalpha.com/news/3448288-pg-and-e-appoints-tvas-johnson-next-ceo-announces-new-board-slate\" target=\"_blank\">criticized the new board slate</a>, saying many lacked experience in the field and  mostly have no ties to California.</li><li>Kelly <a href=\"https://finance.yahoo.com/news/california-regulators-pg-es-vow-004202607.html\" target=\"_blank\">defended their resumes</a>, saying it was \"imperative\" that PG&amp;E board members have financial skills to help the company emerge from bankruptcy protection.</li><li>Kelly said a third of the new slate of directors are current or former California residents, and that he thinks term limits should be applied to the board.</li><li>CPUC President Michael Picker said \"it's safe to say there's still anxiety\" about the new board, to which Kelly said, \"I understand where we are in the trust  factor of everybody in the state of California... and we're just going to have to prove that we can do it.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3451170\" data-linked=\"PG&amp;E defends new board amid skeptic regulators\" data-tweet=\"$PCG - PG&amp;E defends new board amid skeptic regulators https://seekingalpha.com/news/3451170-pg-and-e-defends-new-board-amid-skeptic-regulators?source=tweet\" data-url=\"https://seekingalpha.com/news/3451170-pg-and-e-defends-new-board-amid-skeptic-regulators\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451151\" data-ts=\"1555432935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UHS\" target=\"_blank\">UHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451151-hospital-operators-in-health-insurer-managed-care-downdraft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospital operators in health insurer/managed care downdraft</a></h4><ul><li>The selloff in the managed care/health insurance space precipitated by <a href=\"https://seekingalpha.com/news/3451149-health-insurers-pressure-unh-q1-call\" target=\"_blank\">comments </a>from UnitedHealth's CEO during this morning's earnings call has engulfed hospital operators.</li><li>Apparently adding to the sour mood were comments during Johnson &amp; Johnson's (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+1.8%</font>) Q1 call about modest negative trends in hospital admissions and lab procedures.</li><li>Selected tickers: Universal Health Services (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services, Inc.'>UHS</a> <font color=\"red\">-4.1%</font>); Surgery Partners (<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color=\"red\">-9.8%</font>); SunLink Health Systems (<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc.'>SSY</a>); Select Medical Holdings (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color=\"red\">-3.4%</font>); Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"red\">-8.3%</font>); Community Health Systems (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color=\"red\">-7.1%</font>); HCA Healthcare (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Healthcare, Inc.'>HCA</a> <font color=\"red\">-7.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451151\" data-linked=\"Hospital operators in health insurer/managed care downdraft\" data-tweet=\"$UHS $SGRY $SSY - Hospital operators in health insurer/managed care downdraft https://seekingalpha.com/news/3451151-hospital-operators-in-health-insurer-managed-care-downdraft?source=tweet\" data-url=\"https://seekingalpha.com/news/3451151-hospital-operators-in-health-insurer-managed-care-downdraft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451152\" data-ts=\"1555432820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451152-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers</strong>: Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals, Inc.'>RNN</a>) <font color=\"green\">+28%</font>. UP Fintech Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TIGR' title='UP Fintech Holding Limited'>TIGR</a>) <font color=\"green\">+21%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"green\">+22%</font>. ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"green\">+16%</font>. Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future FinTech Group Inc.'>FTFT</a>) <font color=\"green\">+13%</font>. 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"green\">+13%</font>. FTS International (NYSE:<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a>) <font color=\"green\">+13%</font>. scPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a>) <font color=\"green\">+11%</font>. Piedmont Lithium (NASDAQ:<a href='https://seekingalpha.com/symbol/PLL' title='Piedmont Lithium Limited'>PLL</a>) <font color=\"green\">+11%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers</strong>: Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-47%</font>. ChinaNet Online Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a>) <font color=\"red\">-34%</font>. Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a>) <font color=\"red\">-29%</font>. Aerohive Networks (NYSE:<a href='https://seekingalpha.com/symbol/HIVE' title='Aerohive Networks, Inc.'>HIVE</a>) <font color=\"red\">-17%</font>. Phunware (PHUN) <font color=\"red\">-16%</font>. AAC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) <font color=\"red\">-14%</font>. ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"red\">-14%</font>. Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-13%</font>. Seanergy Maritime Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp.'>SHIP</a>) <font color=\"red\">-11%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451152\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$REXN $TIGR $ICON - Midday Gainers / Losers https://seekingalpha.com/news/3451152-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451152-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451149\" data-ts=\"1555432198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451149-health-insurers-under-pressure-after-unh-q1-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers under pressure after UNH Q1 call</a></h4><ul><li>Health insurers and managed care providers are in the red after UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-3.9%</font>) posted better-than-expected <a href=\"https://seekingalpha.com/news/3450924-unitedhealth-beats-0_13-beats-revenue\" target=\"_blank\">Q1 results</a> this morning, normally a bullish event for the sector. In this case, though, comments by CEO David Wichmann during the conference call that universal insurance coverage would result in a \"wholesale disruption\" in American healthcare appears to have spooked investors, except online insurance exchange operator Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a> <font color=\"green\">+4.2%</font>), albeit on below-average volume.</li><li>Selected tickers: WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-2.7%</font>); Triple-S Management (<a href='https://seekingalpha.com/symbol/GTS' title='Triple-S Management Corporation'>GTS</a> <font color=\"red\">-0.6%</font>); Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"red\">-7%</font>); Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-5.6%</font>); Civitas Solutions (<a href='https://seekingalpha.com/symbol/CIVI' title='Civitas Solutions'>CIVI</a>); Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"red\">-5.2%</font>); Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"red\">-4.5%</font>); Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"red\">-5.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451149\" data-linked=\"Health insurers under pressure after UNH Q1 call\" data-tweet=\"$UNH $HIIQ $WCG - Health insurers under pressure after UNH Q1 call https://seekingalpha.com/news/3451149-health-insurers-under-pressure-after-unh-q1-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3451149-health-insurers-under-pressure-after-unh-q1-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451148\" data-ts=\"1555431780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VFF\" target=\"_blank\">VFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451148-citron-expects-freefall-for-village-farms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron expects freefall for Village Farms</a></h4><ul> <li>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) is <font color=\"red\">down 13.0%</font> after Citron Research initiates a short position and sets a price target of <a href=\"https://citronresearch.com/village-farms-will-the-sec-halt-this-pump-dump/\" target=\"_blank\">$1</a>.</li> <li>\"Village Farms has moved to the dark side by partnering with shady stock promoters that have a track record of failed businesses and JV\u2019s while insiders at both Village Farms and Emerald Health have dumped stock,\" accuses Citron.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451148\" data-linked=\"Citron expects freefall for Village Farms\" data-tweet=\"$VFF - Citron expects freefall for Village Farms https://seekingalpha.com/news/3451148-citron-expects-freefall-for-village-farms?source=tweet\" data-url=\"https://seekingalpha.com/news/3451148-citron-expects-freefall-for-village-farms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451143\" data-ts=\"1555431185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451143-intel-acquires-fpga-solutions-provider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel acquires FPGA solutions provider</a></h4><ul><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <a href=\"https://newsroom.intel.com/news/intel-acquires-omnitek-fpgas/#gs.5zxm84\" target=\"_blank\">acquires</a> Omnitek, provider of optimized video and vision FPGA IP solutions, for undisclosed terms.</li><li>England-based Omnitek has over 220 FPGA IP cores and accompanying software plus 40 employees that will all join Intel's FPGA business in its Programmable Solutions Group. 44</li><li>Intel shares are <font color=\"green\">up 1.6%</font> to $57.18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451143\" data-linked=\"Intel acquires FPGA solutions provider\" data-tweet=\"$INTC - Intel acquires FPGA solutions provider https://seekingalpha.com/news/3451143-intel-acquires-fpga-solutions-provider?source=tweet\" data-url=\"https://seekingalpha.com/news/3451143-intel-acquires-fpga-solutions-provider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451135\" data-ts=\"1555430871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451135-anadarko-perky-on-activist-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko perky on activist report</a></h4><ul><li>According to StreetInsider, <a href=\"https://www.streetinsider.com/Hedge+Funds/Activists+Said+Building+Stakes+in+Anadarko+Petroleum+%28APC%29+in+Push+for+Higher+Bid+-+Sources/15375885.html\" target=\"_blank\">activist investors are </a>building a position in Anadarko Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a>) as they push for a higher bid.</li><li>The Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color=\"green\">+0.6%</font>) deal worked out to about $65 per share at the time it was announced, but reports say Occidental Petroleum had bid in the mid-$70s.</li><li>APC is <font color=\"green\">currently up 2%</font> to $63.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451135\" data-linked=\"Anadarko perky on activist report\" data-tweet=\"$APC $CVX - Anadarko perky on activist report https://seekingalpha.com/news/3451135-anadarko-perky-on-activist-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3451135-anadarko-perky-on-activist-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451125\" data-ts=\"1555430518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451125-iconix-brand-group-leads-consumer-gainers-dean-foods-and-international-paper-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iconix Brand Group leads consumer gainers; Dean Foods and International Paper among losers</a></h4><ul><li><b>Gainers: </b>Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"green\">+19%</font>. Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future FinTech Group Inc.'>FTFT</a>) <font color=\"green\">+16%</font>. BRF (NYSE:<a href='https://seekingalpha.com/symbol/BRFS' title='BRF S.A.'>BRFS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-8%</font>. WestRock (NYSE:<a href='https://seekingalpha.com/symbol/WRK' title='WestRock Company'>WRK</a>) <font color=\"red\">-7%</font>. Arcimoto (NASDAQ:<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a>) <font color=\"red\">-6%</font>. Packaging Corporation of America (NYSE:<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation of America'>PKG</a>) <font color=\"red\">-6%</font>. International Paper (NYSE:<a href='https://seekingalpha.com/symbol/IP' title='International Paper Company'>IP</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451125\" data-linked=\"Iconix Brand Group leads consumer gainers; Dean Foods and International Paper among losers\" data-tweet=\"$ICON $FTFT $BRFS - Iconix Brand Group leads consumer gainers; Dean Foods and International Paper among losers https://seekingalpha.com/news/3451125-iconix-brand-group-leads-consumer-gainers-dean-foods-and-international-paper-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451125-iconix-brand-group-leads-consumer-gainers-dean-foods-and-international-paper-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451123\" data-ts=\"1555430351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451123-fuelcell-energy-cuts-135-workers-shares-slide-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy cuts 135 workers; shares slide 11%</a></h4><ul><li>FuelCell Energy (<a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='red'>-11.6%</font>) plunges a day after <a href=\"https://www.sec.gov/Archives/edgar/data/886128/000114420419019589/tv518882_8k.htm\" target=\"_blank\">cutting nearly a third of its workforce</a> to save $11.5M annually and disclosing the departure of COO Anthony Rauseo.</li><li>A Bloomberg profile out today says FCEL has been \"reduced to a shell of the company it was... With seemingly <a href=\"https://finance.yahoo.com/news/fuel-cell-maker-needs-savior-090101458.html\" target=\"_blank\">no savior waiting in the wings</a>, FuelCell may struggle to stay afloat.\"</li><li>FCEL tells Bloomberg that it is working to attract capital, citing a $23M project financing from Fifth Third Bank for a site in Connecticut and a $100M construction finance facility with Generate Capital.</li><li>NRG Energy has been a key backer and has provided a $40M revolving credit facility to help FCEL build power plants, but that credit line may expire this year, and FCEL faces a grim future without another large investor willing to provide more money at the company's technology, says Roth Capital analyst Craig Irwin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451123\" data-linked=\"FuelCell Energy cuts 135 workers; shares slide 11%\" data-tweet=\"$FCEL - FuelCell Energy cuts 135 workers; shares slide 11% https://seekingalpha.com/news/3451123-fuelcell-energy-cuts-135-workers-shares-slide-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3451123-fuelcell-energy-cuts-135-workers-shares-slide-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>125&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451120\" data-ts=\"1555430195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451120-youngevityplus-5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Youngevity +5% post Q4 results</a></h4><ul><li>Youngevity (<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color=\"green\">+5%</font>) reports <a href=\"https://seekingalpha.com/pr/17477862-youngevity-international-inc-reports-2018-fourth-quarter-full-year-results\" target=\"_blank\">Q4</a> revenue decrease of 12% Y/Y to $36.11M.</li><li>Direct selling segment revenues decreased 9.2% Y/Y to $32.4M and Commercial coffee segment revenues decreased 30.6% Y/Y to $3.7M, this decrease was primarily attributed to timing of shipments in our green coffee business.</li><li>Overall gross margin <font color=\"red\">declined 20 bps</font> to 57.9%; direct selling gross margin also <font color=\"red\">declined 59 bps</font> to 66.36% and gross profit in the commercial coffee segment was a loss of $0.5M compared to a loss of $0.2M Y/Y.</li><li>Adj. EBITDA margin <font color=\"green\">increased 99 bps</font> to 1.72%.</li><li>Cash &amp; equivalents were $2.9M (+332.8% Y/Y) and total stockholders' equity was $22.98M (+208.7% Y/Y).</li><li><b>2019 Guidance:</b> Revenue of $220-240M, which represents a projected annual growth rate between 35%-48% Y/Y; Commercial hemp segment between $45-50M;</li><li>\u201cReturning to profitability remains a key focus of the business for 2019.\" said Dave Briskie, President and CFO of Youngevity International.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451005-youngevity-reports-q4-results\" target=\"_blank\">Youngevity reports Q4 results</a> (Apr. 16 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451120\" data-linked=\"Youngevity +5% post Q4 results\" data-tweet=\"$YGYI - Youngevity +5% post Q4 results https://seekingalpha.com/news/3451120-youngevityplus-5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3451120-youngevityplus-5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451116\" data-ts=\"1555429016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451116-jbs-expected-to-see-rally-due-to-african-swine-fever-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JBS expected to see rally due to African Swine Fever impact</a></h4><ul> <li>JBS (<a href='https://seekingalpha.com/symbol/JBSAF' title='JBS S.A.'>OTC:JBSAF</a>, <a href='https://seekingalpha.com/symbol/JBSAY' title='JBS S.A.'>OTCQX:JBSAY</a>) trades 10% higher in Brazil as the impact of the African Swine Fever in China becomes more significant.</li> <li>Morgan Stanley is on top of the ASF development with an upgrade on JBS to Overweight.</li> <li>\"The market is widely anticipating inflation in protein prices due to the rapid contraction in China's domestic hog herd (over 15% in the last 8 months, or ~7% of global pork supply). We think the rally has only begun and that the long-term impacts of ASF are still not understood,\" advises the firm. In regard to JBS, Morgan Stanley says the company's combination of scale, positioning, spare capacity and access to China sets it apart. The analyst team sees +25% upside to the current equity valuation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451116\" data-linked=\"JBS expected to see rally due to African Swine Fever impact\" data-tweet=\"$JBSAF $JBSAY - JBS expected to see rally due to African Swine Fever impact https://seekingalpha.com/news/3451116-jbs-expected-to-see-rally-due-to-african-swine-fever-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3451116-jbs-expected-to-see-rally-due-to-african-swine-fever-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451109\" data-ts=\"1555428661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TALO\" target=\"_blank\">TALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451109-talos-energy-maintains-high-hopes-for-zama-appraisal-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talos Energy maintains high hopes for Zama appraisal program</a></h4><ul><li>Talos Energy (<a href='https://seekingalpha.com/symbol/TALO' title='Talos Energy Inc.'>TALO</a> <font color='green'>+1.8%</font>) is higher after reporting a <a href=\"https://seekingalpha.com/pr/17477221-talos-energy-provides-additional-update-zama-appraisal-program\" target=\"_blank\">successful appraisal well and  production test</a> at its Zama discovery, located in Block 7 in the offshore portion of Mexico\u2019s prolific Sureste Basin.</li><li>The Zama-2 ST1 appraisal well is the second of three appraisal  penetrations drilled by Talos and its partners to better define the resource potential of the Zama discovery, which is estimated to hold 400M-800M recoverable boe and expected to start production by 2022-23.</li><li>Talos says the production rate of 7,900 boe/day \"from two zones in a very simple  rate-restricted test over only a portion of the total pay column  confirmed our expectations that the Zama wells will provide exceptional  productivity.\"</li><li>Talos is the operator of Block 7 in a consortium with partners Sierra Oil &amp; Gas and Premier  Oil.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451109\" data-linked=\"Talos Energy maintains high hopes for Zama appraisal program\" data-tweet=\"$TALO - Talos Energy maintains high hopes for Zama appraisal program https://seekingalpha.com/news/3451109-talos-energy-maintains-high-hopes-for-zama-appraisal-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3451109-talos-energy-maintains-high-hopes-for-zama-appraisal-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451103\" data-ts=\"1555427309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451103-wired-report-on-sonys-next-gen-console-rattles-videogame-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wired report on Sony&#39;s next-gen console rattles videogame sector</a></h4><ul> <li>Videogame-related stocks are on watch after a Wired <a href=\"https://www.wired.com/story/exclusive-sony-next-gen-console/\" target=\"_blank\">exclusive story</a> on Sony's (<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a> <font color='green'>+0.9%</font>) nex-gen PlayStation indicates that the new console won't be arriving in stores in 2019. The extended release timeframe means some videogame spending could be delayed until the console arrives.</li> <li>Of interest to gamers, Wired's digging says the PlayStation 5 (expected name) will feature a CPU based on the third generation of AMD's Ryzen line and contains eight cores of the new 7nm Zen 2 microarchitecture. The PS5 won't be a cloud-only console and will still be backwards compatible with games for the PS4.</li> <li>Of interest to investors, Activision Blizzard (<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc.'>ATVI</a> <font color='red'>-1.6%</font>), Take-Two Interactive (<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> <font color='red'>-2.3%</font>) and Electronics Arts (<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color='red'>-3.8%</font>) are all lower on the day, while GameStop (<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='green'>+0.9%</font>) is showing a gain.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451103\" data-linked=\"Wired report on Sony&#39;s next-gen console rattles videogame sector\" data-tweet=\"$SNE $ATVI $TTWO - Wired report on Sony&#39;s next-gen console rattles videogame sector https://seekingalpha.com/news/3451103-wired-report-on-sonys-next-gen-console-rattles-videogame-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3451103-wired-report-on-sonys-next-gen-console-rattles-videogame-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451099\" data-ts=\"1555427015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451099-rexahn-pharmaceuticals-leads-healthcare-gainers-aac-holdings-and-lipocine-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn Pharmaceuticals leads healthcare gainers; AAC Holdings and Lipocine among losers</a></h4><ul><li><b>Gainers: </b>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals, Inc.'>RNN</a>) <font color=\"green\">+33%</font>. ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"green\">+19%</font>. LogicBio Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGC' title='LogicBio Therapeutics, Inc.'>LOGC</a>) <font color=\"green\">+8%</font>. ScPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SCPH' title='scPharmaceuticals Inc.'>SCPH</a>) <font color=\"green\">+8%</font>. ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a>) <font color=\"red\">-28%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"red\">-11%</font>. AAC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) <font color=\"red\">-9%</font>. Vermillion (NASDAQ:<a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a>) <font color=\"red\">-9%</font>. Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451099\" data-linked=\"Rexahn Pharmaceuticals leads healthcare gainers; AAC Holdings and Lipocine among losers\" data-tweet=\"$REXN $RWLK $LOGC - Rexahn Pharmaceuticals leads healthcare gainers; AAC Holdings and Lipocine among losers https://seekingalpha.com/news/3451099-rexahn-pharmaceuticals-leads-healthcare-gainers-aac-holdings-and-lipocine-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451099-rexahn-pharmaceuticals-leads-healthcare-gainers-aac-holdings-and-lipocine-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451090\" data-ts=\"1555425649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMC\" target=\"_blank\">OMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451090-52-week-high-for-omicom-after-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">52-week high for Omicom after profit beat</a></h4><ul> <li>Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) is <font color=\"green\">up 5.1%</font> after topping FQ1 profit estimates.</li> <li>The company generated operating profit of $429M during the quarter vs. $411M consensus estimate. The operating profit margin rose 80 bps to 12.4% of sales.</li> <li>Shares of Omnicom traded at a 52-week high of $82.32 earlier in the session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3450940-omnicom-beats-0_07-misses-revenue\" target=\"_blank\">Omnicom beats by $0.07, misses on revenue</a> (April 16)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451090\" data-linked=\"52-week high for Omicom after profit beat\" data-tweet=\"$OMC - 52-week high for Omicom after profit beat https://seekingalpha.com/news/3451090-52-week-high-for-omicom-after-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3451090-52-week-high-for-omicom-after-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451089\" data-ts=\"1555425612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABDC\" target=\"_blank\">ABDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451089-alcentraplus-1_4-after-activist-urges-sale-liquidation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcentra +1.4% after activist urges sale or liquidation</a></h4><ul><li>Alcentra Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/ABDC' title='Alcentra Capital Corporation'>ABDC</a>) <font color=\"green\">gains 1.4% </font>after Stilwell Group says it <a href=\"https://seekingalpha.com/pr/17478269-stilwell-group-mails-letter-shareholders-alcentra-capital-corporation\" target=\"_blank\">has nominated </a>two directors for Alcentra's board and contends that the company should be sold to the highest bidder or liquidated.</li><li>In slides, Stilwell Group argues that the \"only beneficiary of ABDC's continued existence appears to be BNY Mellon, which manages Alcentra.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448731-alcentra-capital-plus-3-percent-strategic-review\" target=\"_blank\">Alcentra Capital +3% on strategic review</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451089\" data-linked=\"Alcentra +1.4% after activist urges sale or liquidation\" data-tweet=\"$ABDC - Alcentra +1.4% after activist urges sale or liquidation https://seekingalpha.com/news/3451089-alcentraplus-1_4-after-activist-urges-sale-liquidation?source=tweet\" data-url=\"https://seekingalpha.com/news/3451089-alcentraplus-1_4-after-activist-urges-sale-liquidation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451086\" data-ts=\"1555425068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451086-meister-takeover-plays-concho-resources-pioneer-natural\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Meister takeover plays: Concho Resources, Pioneer Natural</a></h4><ul><li>Alongside Diamondback Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/FANG' title='Diamondback Energy, Inc.'>FANG</a>), Corvex Management's Keith Meister says Concho Resources (NYSE:<a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a>) and Pioneer Natural Resources (NYSE:<a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a>) are \"must-own\" takeover targets.</li><li>Meister says he'd be \"shocked\" if any of the trio were still independent companies in three-to-five years.</li><li>A catalyst for the M&amp;A animal spirits, says Meister, was last week's Chevron-Anadarko deal.</li><li>FANG and Concho aren't moving much, but Pioneer is <font color=\"green\">higher by 1%</font> in morning action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451078-keith-meister-pitches-diamondback-energy-13d-conference\" target=\"_blank\">Keith Meister pitches Diamondback Energy at 13D conference</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451086\" data-linked=\"More Meister takeover plays: Concho Resources, Pioneer Natural\" data-tweet=\"$FANG $CXO $PXD - More Meister takeover plays: Concho Resources, Pioneer Natural https://seekingalpha.com/news/3451086-meister-takeover-plays-concho-resources-pioneer-natural?source=tweet\" data-url=\"https://seekingalpha.com/news/3451086-meister-takeover-plays-concho-resources-pioneer-natural\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451077\" data-ts=\"1555424194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451077-amdplus-2_4-sony-teases-playstation-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +2.4% as Sony teases PlayStation 5</a></h4><ul><li>Sony (<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a> <font color='green'>+1.2%</font>) previews the PlayStation 5 in an interview with <a href=\"https://www.wired.com/story/exclusive-sony-next-gen-console/\" target=\"_blank\">Wired</a> and the next-gen console will support 8K graphics, 3D audio, and is backward compatible with PlayStation 4 games.</li><li>The new hardware includes an eight-core CPU based on AMD's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) third-gen Ryzen line and a custom GPU based on AMD's Radeon Navi hardware, reiterating an earlier <a href=\"https://www.digitimes.com/news/a20190416PD205.html\" target=\"_blank\">Digitimes </a>report on AMD's 7nm processors and the next-gen PlayStation.</li><li>Sony didn't provide a release date but said it wouldn't release this year. Digitimes suggested AMD's chips would be ready by Q3 2020 for the console's H2 2020 release.</li><li>AMD shares are<font color=\"green\"> up 2.4%</font> to $27.94.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451077\" data-linked=\"AMD +2.4% as Sony teases PlayStation 5\" data-tweet=\"$SNE $AMD - AMD +2.4% as Sony teases PlayStation 5 https://seekingalpha.com/news/3451077-amdplus-2_4-sony-teases-playstation-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3451077-amdplus-2_4-sony-teases-playstation-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451065\" data-ts=\"1555422969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451065-containerboard-stocks-crumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Containerboard stocks crumble</a></h4><ul> <li>Containerboard and paper stocks are down on weak industry data and downgrades from Bank of America Merrill Lynch on Packaging Corp and International Paper to Neutral from Buy.</li> <li>BAML's containerboard breakdown: \"Box shipments were down a surprising 3.0% y/y (on both an actual and average-week basis) while inventories declined 47k tons vs. the typical 70k ton decrease seen over the last 10 years. We had been expecting ~1% growth based on our last survey report and have written that the industry, between maintenance and economic downtime, needs to drop inventories 400- 500k tons between February and June to get back into balance (so about 100k tons or more, per month). The data suggests producers are not being able to manage their excess inventory and production, and we now anticipate increased likelihood of another price cut during 2Q.\"</li> <li>Notable decliners include International Paper (NYSE:<a href='https://seekingalpha.com/symbol/IP' title='International Paper Company'>IP</a>) <font color=\"red\">-5.6%</font>, Sonoco Products (NYSE:<a href='https://seekingalpha.com/symbol/SON' title='Sonoco Products Company'>SON</a>) <font color=\"red\">-2.7%</font>, WestRock (NYSE:<a href='https://seekingalpha.com/symbol/WRK' title='WestRock Company'>WRK</a>) <font color=\"red\">-7.7%</font>, Packaging Corp of America (NYSE:<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation of America'>PKG</a>) <font color=\"red\">-8.2%</font>, Graphic Packaging (NYSE:<a href='https://seekingalpha.com/symbol/GPK' title='Graphic Packaging Holding Company'>GPK</a>) <font color=\"red\">-3.5%</font>, Greif (NYSE:<a href='https://seekingalpha.com/symbol/GEF' title='Greif, Inc.'>GEF</a>) <font color=\"red\">-2.9%</font>, Domtar (NYSE:<a href='https://seekingalpha.com/symbol/UFS' title='Domtar Corporation'>UFS</a>) <font color=\"red\">-2.4%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451065\" data-linked=\"Containerboard stocks crumble\" data-tweet=\"$IP $SON $WRK - Containerboard stocks crumble https://seekingalpha.com/news/3451065-containerboard-stocks-crumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3451065-containerboard-stocks-crumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451064\" data-ts=\"1555422953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451064-pot-stocks-rally-on-bullish-comments-from-canopys-linton\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pot stocks rally on bullish comments from Canopy&#39;s Linton</a></h4><ul><li>Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"green\">+4.1%</font>) is up on average volume in early trade on the heels of comments from Co-CEO Bruce Linton at a conference in Toronto that the company expects to generate over C$1B in sales over the next 12 months.</li><li>Related tickers: Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"green\">+3.6%</font>); Cronos Group (<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group Inc.'>CRON</a> <font color=\"green\">+2.4%</font>); Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"green\">+2.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451064\" data-linked=\"Pot stocks rally on bullish comments from Canopy&#39;s Linton\" data-tweet=\"$CGC $TLRY $CRON - Pot stocks rally on bullish comments from Canopy&#39;s Linton https://seekingalpha.com/news/3451064-pot-stocks-rally-on-bullish-comments-from-canopys-linton?source=tweet\" data-url=\"https://seekingalpha.com/news/3451064-pot-stocks-rally-on-bullish-comments-from-canopys-linton\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451059\" data-ts=\"1555422642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451059-sorrento-establishes-cbd-unit-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento establishes CBD unit; shares up 3%</a></h4><ul><li>Sorrento Therapeutics (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color=\"green\">+3.4%</font>) has set up a new business unit focused on its water soluble cannabidiol &#40;CBD&#41; formulation technology.</li><li>The company says current CBD products are oil-based formulations, usually in sesame or olive oil, that can cause diarrhea in some users. The challenge to date has been the ability to achieve comparable concentrations considering the lipophilic (dissolving efficiently in fats) properties of CBD.</li><li>It has multiple water soluble formulations in stability studies and safety and pharmacokinetic studies in animals are in process. If bioequivalence is confirmed in animals, Sorrento plans to advance certain water-based formulations into human trials aimed at a 505(b)(2) registration pathway which allows the inclusion of data generated by third parties.</li><li>At present, it believes it can achieve CBD concentrates of 5 - 10% (50 - 100 mg/mL) for consumer products.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451059\" data-linked=\"Sorrento establishes CBD unit; shares up 3%\" data-tweet=\"$SRNE - Sorrento establishes CBD unit; shares up 3% https://seekingalpha.com/news/3451059-sorrento-establishes-cbd-unit-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3451059-sorrento-establishes-cbd-unit-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451054\" data-ts=\"1555422160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KGC\" target=\"_blank\">KGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451054-kinross-gold-shakes-up-leadership-coo-roberts-to-depart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinross Gold shakes up leadership; COO Roberts to depart</a></h4><ul><li>Kinross Gold (<a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-2.3%</font>) says Senior VP and COO Lauren Roberts and Senior VP of Human Resources Gina Jardine <a href=\"https://seekingalpha.com/pr/17477983-kinross-announces-changes-senior-leadership-structure\" target=\"_blank\">will leave the company</a> as part of a streamlining of its senior leadership team.</li><li>Paul Tomory will become Executive VP and CTO, broadening his portfolio to take on leadership of regional operations.</li><li>KGC also says Senior VPs of its three operating regions - the Americas, Russia and West Africa - will have increased accountability for the operational success of their respective regions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451054\" data-linked=\"Kinross Gold shakes up leadership; COO Roberts to depart\" data-tweet=\"$KGC - Kinross Gold shakes up leadership; COO Roberts to depart https://seekingalpha.com/news/3451054-kinross-gold-shakes-up-leadership-coo-roberts-to-depart?source=tweet\" data-url=\"https://seekingalpha.com/news/3451054-kinross-gold-shakes-up-leadership-coo-roberts-to-depart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451053\" data-ts=\"1555422097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLKB\" target=\"_blank\">BLKB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451053-blackbaudminus-4-on-salesforce-competition-needham\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blackbaud -4% on Salesforce competition - Needham</a></h4><ul><li>Needham thinks Salesforce.com's <a href=\"https://seekingalpha.com/news/3450851-salesforce-absorbs-independent-nonprofit\" target=\"_blank\">acquisition</a> of nonprofit Salesforce.org poses a competitive threat to Blackbaud (NASDAQ:<a href='https://seekingalpha.com/symbol/BLKB' title='Blackbaud, Inc.'>BLKB</a>) especially if Salesforce increases its investment in the business.</li><li>The firm sees Blackbaud as relatively vulnerable as it retires legacy products and transitions customers to its cloud-based NXT offerings.</li><li>BLKB shares are <font color=\"red\">down 4.2%</font> to $78.78.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451053\" data-linked=\"Blackbaud -4% on Salesforce competition - Needham\" data-tweet=\"$BLKB - Blackbaud -4% on Salesforce competition - Needham https://seekingalpha.com/news/3451053-blackbaudminus-4-on-salesforce-competition-needham?source=tweet\" data-url=\"https://seekingalpha.com/news/3451053-blackbaudminus-4-on-salesforce-competition-needham\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451048\" data-ts=\"1555421604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TS\" target=\"_blank\">TS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451048-argentine-court-reverses-decision-against-tenaris-chairman-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argentine court reverses decision against Tenaris Chairman/CEO</a></h4><ul><li>Tenaris (<a href='https://seekingalpha.com/symbol/TS' title='Tenaris S.A.'>TS</a> <font color=\"green\">+3.6%</font>) opens higher after an Argentine appeals court <a href=\"http://ir.tenaris.com/news-releases/news-release-details/argentine-court-reverses-decision-against-tenariss-ceo-and\" target=\"_blank\">reverses an earlier decision</a> against Chairman and CEO Paolo Rocca \"on the basis of absence of necessary and sufficient grounds to link Mr. Rocca with the proceedings.\"</li><li>In  November 2018, an Argentine first-instance judge issued a preliminary  decision to include Rocca in investigation proceedings after Tenaris's controlling shareholder, Techint Group, was tied to payments allegedly made to government officials.</li><li>The alleged payments reportedly were made in 2008 under duress to secure the safety and repatriation of more than 200 Techint employees and their families in Venezuela, who were being threatened during the Chavez regime's expropriation of Sidor, a Techint Group subsidiary.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451048\" data-linked=\"Argentine court reverses decision against Tenaris Chairman/CEO\" data-tweet=\"$TS - Argentine court reverses decision against Tenaris Chairman/CEO https://seekingalpha.com/news/3451048-argentine-court-reverses-decision-against-tenaris-chairman-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3451048-argentine-court-reverses-decision-against-tenaris-chairman-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451044\" data-ts=\"1555421316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451044-pareteumplus-2-on-maxim-defense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +2% on Maxim defense</a></h4><ul><li>Maxim analyst Allen Klee says he doesn't see \u201cany merit in several negative reports\u201d about Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) and recommends buying on the recent pullback.</li><li>Klee says the \"articles overlook that TEUM is growing at very fast rates organically, acquisitions provide additional growth and new announced wins are not in analyst\u2019s estimates, which should create upside to numbers.\u201d</li><li>Klee tells Bloomberg the articles were from <a href=\"https://seekingalpha.com/symbol/TEUM?s=teum\" target=\"_blank\">Seeking Alpha</a> but didn't specify the articles.</li><li>TEUM shares are <font color=\"green\">up 2%</font> to $4.09.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451044\" data-linked=\"Pareteum +2% on Maxim defense\" data-tweet=\"$TEUM - Pareteum +2% on Maxim defense https://seekingalpha.com/news/3451044-pareteumplus-2-on-maxim-defense?source=tweet\" data-url=\"https://seekingalpha.com/news/3451044-pareteumplus-2-on-maxim-defense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451040\" data-ts=\"1555421230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLF\" target=\"_blank\">GOLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451040-acushnet-looks-to-ride-on-tigers-back-another-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acushnet looks to ride on Tiger&#39;s back another day</a></h4><ul> <li>Acushnet Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GOLF' title='Acushnet Holdings Corp.'>GOLF</a>) is setting up for another up day following the Tiger Wood victory at the Masters.</li> <li>Even James Cramer is talking about the Tiger impact. \"I think the golf renaissance is about to blow up thanks in part to the Tiger Woods effect, and right now the best pure play on the industry is Acushnet Holdings,\" stated Cramer on his Mad Money show last night.</li> <li>Shares of GOLF are <font color=\"green\">up 3.85%</font> in premarket trading to follow on yesterday's 1.65% gain.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451040\" data-linked=\"Acushnet looks to ride on Tiger&#39;s back another day\" data-tweet=\"$GOLF - Acushnet looks to ride on Tiger&#39;s back another day https://seekingalpha.com/news/3451040-acushnet-looks-to-ride-on-tigers-back-another-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3451040-acushnet-looks-to-ride-on-tigers-back-another-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451037\" data-ts=\"1555420927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451037-d-davidson-expects-target-boost-for-e-l-f-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">D.A. Davidson expects Target boost for e.l.f. Beauty</a></h4><ul> <li>Shares of e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty, Inc.'>ELF</a>) rip higher after D.A. Davidson more than doubles its price target on the cosmetics retailer to $15 from $7 as part of an upgrade to a Buy rating.</li> <li>Analyst Linda Bolton Weiser takes a positive stance on ELF after noting increased shelf space at Target for the company's products.</li> <li>In premarket trading, e.l.f. Beauty is <font color=\"green\">up 4.33%</font> to $12.05.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451037\" data-linked=\"D.A. Davidson expects Target boost for e.l.f. Beauty\" data-tweet=\"$ELF - D.A. Davidson expects Target boost for e.l.f. Beauty https://seekingalpha.com/news/3451037-d-davidson-expects-target-boost-for-e-l-f-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3451037-d-davidson-expects-target-boost-for-e-l-f-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451034\" data-ts=\"1555420724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451034-western-digitalplus-2_2-deutsche-goes-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital +2.2% as Deutsche goes Buy</a></h4><ul><li>Deutsche Bank upgrades Western Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) from Hold to Buy citing favorable HDD and NAND data points that support a \"solid\" H2 recovery for earnings.</li><li>The firm notes downside risk to near-term EPS on weaker-than-expected NAND pricing and accordingly cuts its WDC EPS estimates.</li><li>But Deutsche expects reaccelerating nearline HDD demand and NAND industry supply cuts to lead to the stronger recovery.</li><li>The firm raises its price target to $60.</li><li>WDC will report earnings on April 29. Analysts expect $3.68B in revenue with $0.47 EPS.</li><li>WDC shares are <font color=\"green\">up 2.2%</font> pre-market to $53.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451034\" data-linked=\"Western Digital +2.2% as Deutsche goes Buy\" data-tweet=\"$WDC - Western Digital +2.2% as Deutsche goes Buy https://seekingalpha.com/news/3451034-western-digitalplus-2_2-deutsche-goes-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3451034-western-digitalplus-2_2-deutsche-goes-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451030\" data-ts=\"1555420480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451030-zosano-up-5-premarket-on-favorable-study-of-migraine-treatments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano up 5% premarket on favorable study of migraine treatments</a></h4><ul><li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) perks up <font color=\"green\">5%</font> premarket on light volume on the heels of a <a href=\"https://seekingalpha.com/pr/17477854-zosano-announces-publication-analysis-acute-treatments-migraine-headache-journal-head-face\" target=\"_blank\">just-published review</a> in the journal <em>Headache </em>of eight completed migraine trials using new FDA-recommended endpoints of pain freedom and freedom from most bothersome symptom at two hours post-treatment, the co-primary endpoints from its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02745392?term=zotrip&amp;rank=1\" target=\"_blank\">ZOTRIP </a>Phase 3 study of QTRYPTA (zolmitriptan).</li><li>In ZOTRIP, 41.5% of patients receiving 3.8 mg of QTRYPTA achieved pain freedom at hour 2 and 68.3% achieved freedom from their most bothersome symptom at hour 2 compared to 14.3% and 42.9%, respectively, for placebo.</li><li>Using placebo response rates, the authors calculated the required number of subjects for future trials, determining that about 180 participants would be needed to show statistical significance with 80% power, much less than completed studies to date, some enrolling as much as 751 subjects.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451030\" data-linked=\"Zosano up 5% premarket on favorable study of migraine treatments\" data-tweet=\"$ZSAN - Zosano up 5% premarket on favorable study of migraine treatments https://seekingalpha.com/news/3451030-zosano-up-5-premarket-on-favorable-study-of-migraine-treatments?source=tweet\" data-url=\"https://seekingalpha.com/news/3451030-zosano-up-5-premarket-on-favorable-study-of-migraine-treatments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451027\" data-ts=\"1555420259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451027-cnet-and-brs-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNET and BRS among premarket losers</a></h4><ul><li>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-38%</font> after <a href=\"https://seekingalpha.com/news/3450892-bristow-skip-interest-payment-explores-options\" target=\"_blank\">skipping</a> interest payment.</li><li>ChinaNet Online Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a>) <font color=\"red\">-26%</font> on <a href=\"https://seekingalpha.com/news/3450971-chinanet-online-reports-fy-results\" target=\"_blank\">FY results</a>.</li><li>ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"red\">-11%</font>.</li><li>Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) <font color=\"red\">-6%</font>.</li><li>Fibrocell Science (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451027\" data-linked=\"CNET and BRS among premarket losers\" data-tweet=\"$BRS $CNET $AACG - CNET and BRS among premarket losers https://seekingalpha.com/news/3451027-cnet-and-brs-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451027-cnet-and-brs-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451026\" data-ts=\"1555420183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451026-healthcare-dominates-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare dominates premarket gainers</a></h4><ul><li>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals, Inc.'>RNN</a>) <font color=\"green\">+69%</font> on RX-3117 <a href=\"https://seekingalpha.com/news/3451001-rexahn-plus-60-percent-rxminus-3117-collaboration-china\" target=\"_blank\">collaboration</a> in China.</li><li>ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"green\">+17%</font> on <a href=\"https://seekingalpha.com/news/3451015-rewalk-18-percent-premarket-first-exoskeleton-cigna-beneficiary\" target=\"_blank\">first exoskeleton</a> for Cigna beneficiary.</li><li>Motif Bio plc (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"green\">+8%</font> on new Iclaprim <a href=\"https://seekingalpha.com/news/3450976-motif-bio-plus-10-percent-new-iclaprim-data\" target=\"_blank\">data</a>.</li><li>Kamada (NASDAQ:<a href='https://seekingalpha.com/symbol/KMDA' title='Kamada Ltd.'>KMDA</a>) <font color=\"green\">+7%</font> on with <a href=\"https://seekingalpha.com/news/3450968-kamada-go-late-stage-study-inhaled-aat-shares-5-percent-premarket\" target=\"_blank\">late-stage study</a> of Inhaled AAT.</li><li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/pr/17477854-zosano-announces-publication-analysis-acute-treatments-migraine-headache-journal-head-face\" target=\"_blank\">announcing</a> the peer-reviewed publication of a review and analysis of recently-completed trials using newly FDA-recommended endpoints in the acute treatment of migraine.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451026\" data-linked=\"Healthcare dominates premarket gainers\" data-tweet=\"$REXN $RWLK $MTFB - Healthcare dominates premarket gainers https://seekingalpha.com/news/3451026-healthcare-dominates-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451026-healthcare-dominates-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451019\" data-ts=\"1555419784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLD\" target=\"_blank\">PLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451019-prologisplus-2_9-after-forecast-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prologis +2.9% after forecast boost</a></h4><ul><li>Prologis (NYSE:<a href='https://seekingalpha.com/symbol/PLD' title='Prologis, Inc.'>PLD</a>)<font color=\"green\"> jumps 2.9% </font>in premarket trading after<a href=\"https://seekingalpha.com/pr/17477761-prologis-reports-first-quarter-2019-earnings-results\" target=\"_blank\"> boosting</a> 2019 core FFO per share guidance to $3.20-$3.26 from $3.12-$3.20; consensus $3.17.</li><li>Q1 core FFO per share of 73 cents beats consensus estimate of 72 cents and compares with 80 cents in the year-ago period.</li></ul><ol><li>No promotes earned in Q1 2019 vs. net promote income of 9 cents per share in the year-ago period.</li></ol><ul><li>Q1 Prologis share cash same-store NOI rose 5.5% vs. 7.9% in the year-ago quarter.</li><li>Q1 net effective rent change of 25.1% vs. 21.9% a year ago; U.S. rose 30.8%, while Europe</li><li>Occupancy of 96.8% at end of Q1 2019, the same as a year earlier.</li><li><a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2437014-1&amp;h=2268138511&amp;u=http%3A%2F%2Fir.prologis.com%2F&amp;a=http%3A%2F%2Fir.prologis.com+\" target=\"_blank\">Conference call </a>at 12:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3450986-prologis-beats-0_01-beats-revenue\" target=\"_blank\">Prologis beats by $0.01, beats on revenue</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451019\" data-linked=\"Prologis +2.9% after forecast boost\" data-tweet=\"$PLD - Prologis +2.9% after forecast boost https://seekingalpha.com/news/3451019-prologisplus-2_9-after-forecast-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3451019-prologisplus-2_9-after-forecast-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451015\" data-ts=\"1555419316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451015-rewalk-up-18-premarket-on-first-exoskeleton-for-cigna-beneficiary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk up 18% premarket on first exoskeleton for Cigna beneficiary</a></h4><ul><li>Nano cap ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) is up <font color=\"green\">18%</font> premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17477863-rewalk-announces-first-personal-exoskeleton-provided-cigna-beneficiary\" target=\"_blank\">announcement </a>that the first Cigna beneficiary has received a ReWalk Personal 6.0 exoskeleton. The man sustained a spinal cord injury in a motorcycle accident in 2016.</li><li>The company says it has delivered more than 500 exoskeleton devices to date.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451015\" data-linked=\"ReWalk up 18% premarket on first exoskeleton for Cigna beneficiary\" data-tweet=\"$RWLK - ReWalk up 18% premarket on first exoskeleton for Cigna beneficiary https://seekingalpha.com/news/3451015-rewalk-up-18-premarket-on-first-exoskeleton-for-cigna-beneficiary?source=tweet\" data-url=\"https://seekingalpha.com/news/3451015-rewalk-up-18-premarket-on-first-exoskeleton-for-cigna-beneficiary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451014\" data-ts=\"1555419312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERN\" target=\"_blank\">CERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451014-starboards-smith-boosts-kar-auction-cerner\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starboard&#39;s Smith boosts KAR Auction, Cerner</a></h4><ul><li><a href=\"https://www.13dmonitorconference.com/\" target=\"_blank\">Speaking at the 13D</a> Monitor Active-Passive Investor Summit, Starboard Value's Jeff Smith says Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) remains cheap even after recent gains. Margin targets are reasonable and achievable, he says, and an opportunity to improve governance and leadership remains. Shares are <font color=\"green\">up 1% </font>premarket.</li><li>He's got a new idea as well in KAR Auction Services (NYSE:<a href='https://seekingalpha.com/symbol/KAR' title='KAR Auction Services, Inc.'>KAR</a>). Valuation, he says, is incredibly cheap for this great business with secular tailwinds. There's also opportunity in spinning of the salvage operation. Shares are <font color=\"green\">up 5.25%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451014\" data-linked=\"Starboard&#39;s Smith boosts KAR Auction, Cerner\" data-tweet=\"$CERN $KAR - Starboard&#39;s Smith boosts KAR Auction, Cerner https://seekingalpha.com/news/3451014-starboards-smith-boosts-kar-auction-cerner?source=tweet\" data-url=\"https://seekingalpha.com/news/3451014-starboards-smith-boosts-kar-auction-cerner\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451010\" data-ts=\"1555418711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYO\" target=\"_blank\">MYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451010-myomo-inks-deal-for-myopro-in-chile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myomo inks deal for MyoPro in Chile</a></h4><ul> <li>Myomo (NYSEMKT:<a href='https://seekingalpha.com/symbol/MYO' title='Myomo, Inc.'>MYO</a>) has <a href=\"https://seekingalpha.com/pr/17477755-myomo-announces-new-sales-service-agreement-chile\" target=\"_blank\">signed</a> an agreement with Tecnoplanta Orthopedic       Laboratory with the goal of offering MyoPro in Chile.</li><li><a href=\"https://myomo.com/what-is-a-myopro-orthosis/\" target=\"_blank\">MyoPro</a> is wearable device that restores function in paralyzed or weakened arms and hands in patients who have suffered an injury or stroke.</li><li>Shares are up <font color=\"green\">15%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3451010\" data-linked=\"Myomo inks deal for MyoPro in Chile\" data-tweet=\"$MYO - Myomo inks deal for MyoPro in Chile https://seekingalpha.com/news/3451010-myomo-inks-deal-for-myopro-in-chile?source=tweet\" data-url=\"https://seekingalpha.com/news/3451010-myomo-inks-deal-for-myopro-in-chile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451004\" data-ts=\"1555418330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGR\" target=\"_blank\">PGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451004-progressive-beats-0_48-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progressive beats by $0.48, beats on revenue</a></h4><ul><li>Progressive (NYSE:<a href='https://seekingalpha.com/symbol/PGR' title='The Progressive Corporation'>PGR</a>): Q1 GAAP EPS of $1.83 <span style=\"color:green\">beats by $0.48</span>.</li><li>Revenue of $9.24B (+15.9% Y/Y) <font color=\"green\">beats by $40M</font>.</li><li>Shares <font color=\"green\">+1.5%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17477829-progressive-reports-march-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3451004\" data-linked=\"Progressive beats by $0.48, beats on revenue\" data-tweet=\"$PGR - Progressive beats by $0.48, beats on revenue https://seekingalpha.com/news/3451004-progressive-beats-0_48-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3451004-progressive-beats-0_48-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451001\" data-ts=\"1555417984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451001-rexahnplus-60-on-rxminus-3117-collaboration-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn +60% on RX-3117 collaboration in China</a></h4><ul> <li>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals, Inc.'>RNN</a>) and BioSense Global LLC, a New Jersey and China-based biopharma company, have entered into a <a href=\"https://seekingalpha.com/pr/17477673-rexahn-biosense-global-announce-collaboration-license-agreement-rxminus-3117-greater-china\" target=\"_blank\">collaboration</a> and license agreement to develop and commercialize RX-3117 for pancreatic cancer and other cancers in Greater China.</li>   <li>Under the agreement, Rexahn will grant BioSense an exclusive license for RX-3117. Rexahn will receive an upfront payment and will be eligible to receive additional milestones up to a total of $226M.</li><li>Rexahn will also be eligible to receive tiered royalties in the low double digits to mid teens on annual net sales in the territory.</li><li>BioSense will fund all related activities and will initiate a Phase 2 study to evaluate the drug candidate in up to three additional indications not previously studied by Rexahn.</li>    <li>RX-3117 is an investigational, oral, small molecule nucleoside compound.</li><li>RNN shares are up <font color=\"green\">60%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451001\" data-linked=\"Rexahn +60% on RX-3117 collaboration in China\" data-tweet=\"$RNN $REXN - Rexahn +60% on RX-3117 collaboration in China https://seekingalpha.com/news/3451001-rexahnplus-60-on-rxminus-3117-collaboration-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3451001-rexahnplus-60-on-rxminus-3117-collaboration-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450997\" data-ts=\"1555417259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WVE\" target=\"_blank\">WVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450997-wave-life-sci-presents-final-safety-data-on-dmd-candidate-suvodirsen-shares-down-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wave Life Sci presents final safety data on DMD candidate suvodirsen; shares down 11% premarket</a></h4><ul><li>Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a>) slips <font color=\"red\">11%</font> premarket on light volume on the heels of final <a href=\"https://seekingalpha.com/pr/17477545-wave-life-sciences-announces-suvodirsen-phase-1-safety-tolerability-data-phase-2-3-clinical\" target=\"_blank\">safety and tolerability data</a> on Duchenne muscular dystrophy &#40;DMD&#41; candidate suvodirsen (WVE-210201) that appears worse than Sarepta's EXONDYS 51 (eteplirsen). The results are being presented today at the Muscular Dystrophy Association Clinical and Scientific Conference in Orlando, FL.</li><li>36 DMD patients received one of five ascending doses of suvodirsen or placebo and were followed for 85 days. No serious adverse events, deaths or discontinuations were reported.</li><li>67% (n=16/24) of participants who received suvodirsen and 80% (n=8/10) of those receiving placebo experienced one or more adverse events (AEs). The most common AEs, all mild or moderate, in the suvodirsen group were pyrexia (high temperature), headache, vomiting and tachycardia (rapid heart rate), all consistent with infusion-related reactions. All resolved spontaneously or with symptomatic treatment.</li><li>Safety data on EXONDYS 51 showed a 38% rate of balance disorder and vomiting and 25% rate of contact dermatitis at 1.7x the recommended dosage.</li><li>The company will initiate a Phase 2/3 trial, DYSTANCE 51, in DMD boys amenable to exon 51 skipping in July. Participants will receive 4.5 mg/kg or 3 mg/kg of suvodirsen or placebo administered intravenously once per week for 48 weeks. The primary endpoints will be the change in dystrophin protein level and the change in North Star Ambulatory Assessment score.</li><li>Interim muscle biopsy data from an ongoing open-label extension study should be available in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450997\" data-linked=\"Wave Life Sci presents final safety data on DMD candidate suvodirsen; shares down 11% premarket\" data-tweet=\"$WVE - Wave Life Sci presents final safety data on DMD candidate suvodirsen; shares down 11% premarket https://seekingalpha.com/news/3450997-wave-life-sci-presents-final-safety-data-on-dmd-candidate-suvodirsen-shares-down-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3450997-wave-life-sci-presents-final-safety-data-on-dmd-candidate-suvodirsen-shares-down-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450995\" data-ts=\"1555416997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450995-citi-sees-upside-on-cummins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi sees upside on Cummins</a></h4><ul> <li>Citi upgrades Cummins (NYSE:<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a>) to a Buy rating from Neutral.</li> <li>\"We see upside to 2019 estimates, and think out-year cash flows stay higher for longer. Continued improvement in China/EM sentiment should help to support a higher multiple,\" reads the firm's bull pitch.</li> <li>The Citi analyst team assigns a price target of $190 to Cummins.</li><li>CMI <font color=\"green\">+1.51%</font> premarket to $167.46.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450995\" data-linked=\"Citi sees upside on Cummins\" data-tweet=\"$CMI - Citi sees upside on Cummins https://seekingalpha.com/news/3450995-citi-sees-upside-on-cummins?source=tweet\" data-url=\"https://seekingalpha.com/news/3450995-citi-sees-upside-on-cummins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450993\" data-ts=\"1555416821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450993-netflixplus-2-on-deutsche-bank-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix +2% on Deutsche Bank confidence</a></h4><ul> <li>Deutsche Bank <a href=\"https://www.cnbc.com/2019/04/16/deutsche-bank-buy-netflix-as-it-becomes-a-global-cultural-necessity.html\" target=\"_blank\">lifts</a> Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) to a Buy rating from Hold on its view that no other streaming platforms are close to the company's reach.</li>  <li>\"Platform status brings network effects not available to peers and competitors. Specifically, this is making Netflix even more of a go-to destination when consumers want to watch something, and it means having Netflix is becoming more of a cultural necessity for people around the world,\" says DB analyst Bryan Kraft.</li> <li>The firm hikes its price target on NFLX to $400.</li> <li>Shares of Netflix are <font color=\"green\">up 1.66%</font> in premarket action after a couple of shaky days of trading following the Disney+ unveiling. Earnings drop later today from the streaming juggernaut.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450993\" data-linked=\"Netflix +2% on Deutsche Bank confidence\" data-tweet=\"$NFLX - Netflix +2% on Deutsche Bank confidence https://seekingalpha.com/news/3450993-netflixplus-2-on-deutsche-bank-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3450993-netflixplus-2-on-deutsche-bank-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450986\" data-ts=\"1555416338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLD\" target=\"_blank\">PLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450986-prologis-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prologis beats by $0.01, beats on revenue</a></h4><ul><li>Prologis (NYSE:<a href='https://seekingalpha.com/symbol/PLD' title='Prologis, Inc.'>PLD</a>): Q1 FFO of $0.73 <font color=\"green\">beats by $0.01</font>; GAAP EPS of $0.55.</li><li>Revenue of $772.05M (+11.2% Y/Y) <font color=\"green\">beats by $84.84M</font>.</li><li>Shares <font color=\"green\">+2.4%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17477761-prologis-reports-first-quarter-2019-earnings-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450986\" data-linked=\"Prologis beats by $0.01, beats on revenue\" data-tweet=\"$PLD - Prologis beats by $0.01, beats on revenue https://seekingalpha.com/news/3450986-prologis-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3450986-prologis-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450978\" data-ts=\"1555415718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450978-titan-pharma-files-for-50m-mixed-shelf-shares-down-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharma files for $50M mixed shelf; shares down 4% premarket</a></h4><ul><li>Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/910267/000114420419019741/tv518929_s3a.htm\" target=\"_blank\">prospectus </a>for a $50M mixed shelf offering.</li><li>Shares are down <font color=\"red\">4%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450978\" data-linked=\"Titan Pharma files for $50M mixed shelf; shares down 4% premarket\" data-tweet=\"$TTNP - Titan Pharma files for $50M mixed shelf; shares down 4% premarket https://seekingalpha.com/news/3450978-titan-pharma-files-for-50m-mixed-shelf-shares-down-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3450978-titan-pharma-files-for-50m-mixed-shelf-shares-down-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450977\" data-ts=\"1555415713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450977-trucking-names-mull-poor-j-b-hunt-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trucking names mull poor J.B. Hunt results</a></h4><ul><li>J.B. Hunt (NASDAQ:<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a>) is <font color=\"red\">down just shy of 5%</font> in premarket action after missing on both the top and bottom lines last night. The company took note of poor winter weather and higher salaries.</li><li>Morgan Stanley this morning cuts its price target to a Street-low $95 vs. the $105.50 close yesterday and the current $100.30.</li><li>Trucking names of interest: U.S. Xpress (NYSE:<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises, Inc.'>USX</a>), Heartland Express (NASDAQ:<a href='https://seekingalpha.com/symbol/HTLD' title='Heartland Express, Inc.'>HTLD</a>), Textainer Group (NYSE:<a href='https://seekingalpha.com/symbol/TGH' title='Textainer Group Holdings Limited'>TGH</a>), Expeditors International (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPD' title='Expeditors International of Washington, Inc.'>EXPD</a>), USA Truck (NASDAQ:<a href='https://seekingalpha.com/symbol/USAK' title='USA Truck, Inc.'>USAK</a>), Knight-Swift (NYSE:<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a>), Landstar (NASDAQ:<a href='https://seekingalpha.com/symbol/LSTR' title='Landstar System, Inc.'>LSTR</a>), Werner Enterprises (NASDAQ:<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3450809-j-b-hunt-transport-services-misses-0_16-misses-revenue\" target=\"_blank\">J.B. Hunt Transport Services misses by $0.16, misses on revenue</a> (April 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3450818-j-b-hunt-transport-minus-5-percent-earnings-miss\" target=\"_blank\">J.B. Hunt Transport -5% after earnings miss</a> (April 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3450977\" data-linked=\"Trucking names mull poor J.B. Hunt results\" data-tweet=\"$JBHT $USX $HTLD - Trucking names mull poor J.B. Hunt results https://seekingalpha.com/news/3450977-trucking-names-mull-poor-j-b-hunt-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3450977-trucking-names-mull-poor-j-b-hunt-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450976\" data-ts=\"1555415474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTFB\" target=\"_blank\">MTFB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450976-motif-bioplus-10-on-new-iclaprim-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Motif Bio +10% on new Iclaprim data</a></h4><ul> <li>Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <a href=\"https://seekingalpha.com/pr/17477326-motif-bio-presents-new-iclaprim-data-eccmid-2019\" target=\"_blank\">reports</a> new iclaprim data at the 28<sup>th</sup> European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019) in Amsterdam, The Netherlands.</li>       <li>Efficacy analysis by lesion size demonstrates iclaprim had comparable efficacy to vancomycin across broad range of lesion sizes in REVIVE Phase III study patients.</li>            <li>Clearance of bacteremia comparable in patients treated with iclaprim versus vancomycin in pooled analysis of REVIVE Phase III study results.</li>                              <li>Data show that iclaprim continues to be active against Gram-positive skin and soft structure pathogens collected from patients with skin and skin structure infections.</li>            <li>Real-world incidence of vancomycin-associated nephrotoxicity in hospitalised patients with ABSSSI shown to be  &gt;3-fold higher than in recent trials.</li><li>Shares are up <font color=\"green\">10%</font> premarket.</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3450976\" data-linked=\"Motif Bio +10% on new Iclaprim data\" data-tweet=\"$MTFB $MTFBF - Motif Bio +10% on new Iclaprim data https://seekingalpha.com/news/3450976-motif-bioplus-10-on-new-iclaprim-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3450976-motif-bioplus-10-on-new-iclaprim-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450973\" data-ts=\"1555415174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGIX\" target=\"_blank\">CGIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450973-cancer-genetics-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cancer Genetics beats by $0.02, beats on revenue</a></h4><ul><li>Cancer Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>): Q4 GAAP EPS of -$0.14 <span style=\"color:green\">beats by $0.02</span>.</li><li>Revenue of $6.8M (-9.3% Y/Y) <font color=\"green\">beats by $0.5M</font>.</li><li>Shares <font color=\"green\">+1.4%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17477567-cancer-genetics-reports-fourth-quarter-full-year-2018-financial-results-provides-strategic\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450973\" data-linked=\"Cancer Genetics beats by $0.02, beats on revenue\" data-tweet=\"$CGIX - Cancer Genetics beats by $0.02, beats on revenue https://seekingalpha.com/news/3450973-cancer-genetics-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3450973-cancer-genetics-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450968\" data-ts=\"1555414915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMDA\" target=\"_blank\">KMDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450968-kamada-on-go-late-stage-study-of-inhaled-aat-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kamada on go with late-stage study of Inhaled AAT; shares up 5% premarket</a></h4><ul><li>Kamada (NASDAQ:<a href='https://seekingalpha.com/symbol/KMDA' title='Kamada Ltd.'>KMDA</a>) is up <font color=\"green\">5%</font> premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17477528-kamada-announces-fda-acceptance-inhaled-aat-program-path-forward\" target=\"_blank\">announcement </a>that the FDA has finally signed off on a Phase 3 clinical trial evaluating its Inhaled Alpha-1-Antitrypsin (Inhaled AAT) for the treatment of Alpha-1 Antitrypsin Deficiency &#40;AATD&#41;. The study should launch in H2 contingent on the successful completion of a human factor study that will be initiated this quarter assessing the combination of Inhaled AAT and PARI Pharma GmbH's eFlow nebulizer device.</li><li>The company had been <a href=\"https://seekingalpha.com/news/3347587-kamada-still-phase-3-protocol-inhaled-aat-therapy\" target=\"_blank\">waiting for the FDA nod</a> since July 2017. It has taken this long for the agency to get comfortable with the safety and efficacy issues which Kamada addressed with additional data and information.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450968\" data-linked=\"Kamada on go with late-stage study of Inhaled AAT; shares up 5% premarket\" data-tweet=\"$KMDA - Kamada on go with late-stage study of Inhaled AAT; shares up 5% premarket https://seekingalpha.com/news/3450968-kamada-on-go-late-stage-study-of-inhaled-aat-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3450968-kamada-on-go-late-stage-study-of-inhaled-aat-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450963\" data-ts=\"1555414569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450963-nio-shows-off-new-model\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nio shows off new model</a></h4><ul> <li>Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) is <a href=\"https://www.autonews.com/shanghai-auto-show/nio-teases-upcoming-sedan-et-preview\" target=\"_blank\">previewing</a> a new sedan at the Shanghai Auto Show this week.</li> <li>Nio CEO William Li says the sedan rounds out the brand's lineup that already has the ES6 and ES8 featured.</li> <li>The Chinese EV automaker hasn't set a launch date yet for the ET Preview.</li> <li><a href=\"https://www.topgear.com/car-news/shanghai-motor-show/nios-tesla-and-polestar-rival\" target=\"_blank\">ET Preview pictures courtesy of Topgear.com</a>.</li> <li>Shares of Nio are <font color=\"green\">up 1.47%</font> in premarket trading to $4.82.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450963\" data-linked=\"Nio shows off new model\" data-tweet=\"$NIO - Nio shows off new model https://seekingalpha.com/news/3450963-nio-shows-off-new-model?source=tweet\" data-url=\"https://seekingalpha.com/news/3450963-nio-shows-off-new-model\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450962\" data-ts=\"1555414227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450962-crispr-and-vertexs-ctx001-fast-trackd-for-beta-thalassemia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR and Vertex&#39;s CTX001 Fast Track&#39;d for beta thalassemia</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17477568-crispr-therapeutics-vertex-announce-fda-fast-track-designation-ctx001-treatment-beta\" target=\"_blank\">designates </a>CRISPR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a>) and development partner Vertex Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>) gene therapy candidate CTX001 for Fast Track review for the treatment of transfusion-dependent beta thalassemia.</li><li>A Phase 1/2 open-label study launched in February.</li><li>CTX001 is also Fast Track-tagged for sickle cell disease. The first patient should be infused mid-year.</li><li>Fast Track status provides for more frequent interaction with the FDA review team and a rolling review of the marketing application.</li><li>CRSP is up <font color=\"green\">4%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450962\" data-linked=\"CRISPR and Vertex&#39;s CTX001 Fast Track&#39;d for beta thalassemia\" data-tweet=\"$CRSP $VRTX - CRISPR and Vertex&#39;s CTX001 Fast Track&#39;d for beta thalassemia https://seekingalpha.com/news/3450962-crispr-and-vertexs-ctx001-fast-trackd-for-beta-thalassemia?source=tweet\" data-url=\"https://seekingalpha.com/news/3450962-crispr-and-vertexs-ctx001-fast-trackd-for-beta-thalassemia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450960\" data-ts=\"1555413818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTT\" target=\"_blank\">QTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450960-qutoutiaoplus-3_6-on-citi-upgrade-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qutoutiao +3.6% on Citi upgrade (update)</a></h4><ul><li>Citi upgrades Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) from Neutral to Buy but trims the target from $16 to $14 due to the high share count and a slight estimates revision.</li><li>Earlier this month, QTT <a href=\"https://seekingalpha.com/news/3448452-qutoutiao-announces-pricing-upsized-follow-public-offering-ads\" target=\"_blank\">priced</a> an offering of 3.3M shares from the company and 6.7M by selling shareholders.</li><li>QTT shares are <font color=\"green\">up 3.6%</font> pre-market to $9.05.</li><li>More details from the upgrade:</li><li>Analyst Alicia Yap cites an improved risk/reward balance after the 24% pullback that followed the secondary offering.</li><li>Yap says user counts remained solid last month and the company could capitalize on deeper collabs with Taobao merchants and Alibaba's marketing cloud for user retention.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450960\" data-linked=\"Qutoutiao +3.6% on Citi upgrade (update)\" data-tweet=\"$QTT - Qutoutiao +3.6% on Citi upgrade (update) https://seekingalpha.com/news/3450960-qutoutiaoplus-3_6-on-citi-upgrade-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3450960-qutoutiaoplus-3_6-on-citi-upgrade-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450959\" data-ts=\"1555413763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450959-gilead-teams-up-insitro-in-nash-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead teams up with insitro in NASH; shares up 1% premarket</a></h4><ul><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) is up <font color=\"green\">1%</font> premarket on light volume in reaction to its three-year <a href=\"https://seekingalpha.com/pr/17477509-gilead-insitro-announce-strategic-collaboration-discover-develop-novel-therapies-nonalcoholic\" target=\"_blank\">collaboration </a>with privately held <a href=\"http://insitro.com/\" target=\"_blank\">insitro</a> to discover and development treatments for nonalcoholic steatohepatitis &#40;NASH&#41;.</li><li>The partnership will leverage insitro's proprietary platform &#40;ISH&#41; to create NASH disease models and discover targets that influence clinical progression and regression of the disease.</li><li>Under the terms of the agreement, GILD will pay insitro $15M upfront, up to $35M in near-term payments, up to $200M in milestones for each of five targets and up to low double-digit royalties on net sales. In the programs where insitro opts in, it will have the right to co-develop and co-detail in the U.S., receive a share of the profits in China and receive milestone payments and royalties on ex-U.S. sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450959\" data-linked=\"Gilead teams up with insitro in NASH; shares up 1% premarket\" data-tweet=\"$GILD - Gilead teams up with insitro in NASH; shares up 1% premarket https://seekingalpha.com/news/3450959-gilead-teams-up-insitro-in-nash-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3450959-gilead-teams-up-insitro-in-nash-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450947\" data-ts=\"1555412459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450947-jnj-up-1-premarket-on-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JNJ up 1% premarket on Q1 beat</a></h4><ul><li>Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) <a href=\"https://seekingalpha.com/pr/17477482-johnson-and-johnson-reports-2019-first-quarter-results\" target=\"_blank\">Q1 results</a>: Revenues: $20,021M (+0.1%); Consumer: $3,318M (-2.4%); Pharmaceuticals: $10,244M (+4.1%); Medical Devices: $6,459M (-4.6%).</li><li>Net Income: $3,749M (-14.2%); EPS: $1.39 (-13.1%); Non-GAAP EPS: $2.10 (+1.9%); Non-GAAP Net Income: $5,661M (+0.5%).</li><li>Key Product Sales: Remicade: $1,102M (-20.6%); Simponi/Simponi Aria: $524M (+1.0%); Stelara: $1,405M (+32.4%); Darzalex: $629M (+45.5%); Xarelto: $542M (-6.3%); Zytiga: $679M (-19.6%); Imbruvica: $784M (+33.5%); Velcade: $263M (-16.0%); Invega sustennn/Xeplion/Trinza/Trevicta: $790M (+13.5%); EDURANT/rilpivirine: $211M (+0.8%); Prezista/Prezcobix/Rezolsta/Symtuza: $523M (+9.5%); Precrit/Eprex: $226M (-18.0%).</li><li><strong>2019 Guidance</strong>: Revenues: $80.4B - $81.2B (unch); Non-GAAP EPS: $8.53 - 8.63 from $8.50 - 8.65.</li><li>Shares are up <font color=\"green\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450947\" data-linked=\"JNJ up 1% premarket on Q1 beat\" data-tweet=\"$JNJ - JNJ up 1% premarket on Q1 beat https://seekingalpha.com/news/3450947-jnj-up-1-premarket-on-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3450947-jnj-up-1-premarket-on-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}